Stay updated with breaking news from Sancy Leachman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- In a first-in-human study, researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin...
SEASIDE — Columbia Memorial Hospital, Oregon Health & Science University and Frontier Dermatology are holding a free SPOTme skin cancer screening from 9 a.m. to 2 p.m. Sept. 30 at
Primary care might be the first setting where AI-driven tools allow for broader access to effective melanoma screening, amid continuing challenges in developing consumer apps for this purpose.
Addressing racial disparities in skin cancer involves education, understanding rates of risk and ethnicity, and knowledge of the different types of melanoma, which makes skin cancer disparities complex to attack, said Sancy Leachman, MD, PhD, professor and chair in the Department of Dermatology and director of the Melanoma Research Program at the Knight Cancer Institute at Oregon Health and Science University.
Dermatologists say a tiny spot was discovered on a patient's cheek measuring just 0.65 millimeters or 0.025 inches.